Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human HepG2 cells and obese mice

Nutrition Research

Volumn 31, Issue 12, 2011, Pages 896-906

  Hwang, Yong Pil ^a,d   Choi, Jae Ho ^a   Han, Eun Hee ^a   Kim, Hyung Gyun ^a   Wee, Ji Hyang ^b   Jung, Kyung Ok ^b   Jung, Kyung Hee ^b   Kwon, Kwang il ^a   Jeong, Tae Cheon ^c   Chung, Young Chul ^d   Jeong, Hye Gwang ^a  

^a Chungnam National University   (South Korea)

^b Jeonnam Bioindustry Foundation   (South Korea)

^c Yeungnam University   (South Korea)

^d International University of Korea   (South Korea)

Author keywords

AMPK; Anthocyanins; Fatty acid synthase; High fat diet; Mice; Purple sweet potato

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE; ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE INHIBITOR; ANTHOCYANIN; ENZYME INHIBITOR; FATTY ACID SYNTHASE; PROTEIN KINASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BODY FAT; BODY WEIGHT; CELL STRAIN HEPG2; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FATTY LIVER; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; INSTITUTE FOR CANCER RESEARCH MOUSE; LIPID BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER HISTOLOGY; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PURPLE SWEET POTATO; SIGNAL TRANSDUCTION; SWEET POTATO; WEIGHT GAIN; WESTERN BLOTTING;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTHOCYANINS; BLOTTING, WESTERN; DIETARY FATS; ENZYME ACTIVATION; FATTY ACID SYNTHETASE COMPLEX; FUNCTIONAL FOOD; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATOCYTES; HUMANS; IPOMOEA BATATAS; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED ICR; MICE, OBESE; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; PLANT TUBERS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; WEIGHT GAIN;

EID: 83355160600     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.09.026     Document Type: Article

References (56)

1. Marchesini G., Brizi M., Bianchi G., Tomassetti S., Buqianesi E., Lenzi M. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50:1844-1850.
2. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89:331-340.
3. Zhang B.B., Zhou G., Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 2009, 9:407-416.
4. Viollet B., Foretz M., Guigas B., Horman S., Dentin R., Bertrand L., et al. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol 2006, 574:41-53.
5. Lee M.S., Kim D., Jo K., Hwang J.K. Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice. Biochem Biophys Res Commun 2010, 401:92-97.
6. Rawson R.B. Control of lipid metabolism by regulated intramembrane proteolysis of sterol regulatory element binding proteins (SREBPs). Biochem Soc Symp 2003, 70:221-231.
7. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002, 109:1125-1131.
8. Yahagi N., Shimano H., Hasty A.H., Matsuzaka T., Ide T., Yoshikawa T. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem 2002, 277:19353-19357.
9. Kim Y.W., Kim Y.M., Yang Y.M., Kim T.H., Hwang S.J., Lee J.R. Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis. Free Radic Biol Med 2010, 48:567-578.
10. Lee Y.K., Lee W.S., Kim G.S., Park O.J. Anthocyanins are novel AMPKα1 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation. Oncol Rep 2010, 24:1471-1477.
11. Shih P.H., Yeh C.T., Yen G.C. Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis. J Agric Food Chem 2007, 55:9427-9435.
12. Karlsen A., Retterstøl L., Laake P., Paur I., Kjølsrud-Bøhn S., Sandvik L. Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr 2007, 137:1951-1954.
13. Shih P.H., Yeh C.T., Yen G.C. Effects of anthocyanidin on the inhibition of proliferation and induction of apoptosis in human gastric adenocarcinoma cells. Food Chem Toxicol 2005, 43:1557-1566.
14. Tsuda T., Horio F., Uchida K., Aoki H., Osawa T. Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J Nutr 2003, 133:2125-2130.
15. Prior R.L., Wu X., Gu L., Hager T.J., Hager A., Howard L.R. Whole berries versus berry anthocyanins: interactions with dietary fat levels in the C57BL/6J mouse model of obesity. J Agric Food Chem 2008, 56:647-653.
16. Takikawa M., Inoue S., Horio F., Tsuda T. Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J Nutr 2010, 140:527-533.
17. Tsuda T., Ueno Y., Yoshikawa T., Kojo H., Osawa T. Microarray profiling of gene expression in human adipocytes in response to anthocyanins. Biochem Pharmacol 2006, 71:1184-1197.
18. Tsuda T. Regulation of adipocyte function by anthocyanins; possibility of preventing the metabolic syndrome. J Agric Food Chem 2008, 56:642-646.
19. Sasaki R., Nishimura N., Hoshino H., Isa Y., Kadowaki M., Ichi T., et al. Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem Pharmacol 2007, 74:1619-1627.
20. Lila M.A. Anthocyanins and human health: an in vitro investigative approach. J Biomed Biotechnol 2004, 5:306-313.
21. Odake K., Terahara N., Saito N., Toki K., Honda T. Chemical structures of two anthocyanins from purple sweet potatoes Ipomoea batatas. Phytochemistry 1992, 31:2127-2130.
22. Goda Y., Shimizu T., Kato Y., Nakamura M., Maitani T., Yamada T. Two acylated anthocyanins from purple sweet potato. Phytochemistry 1997, 18:183-186.
23. Qiu F., Luo J., Yao S., Ma L., Kong L. Preparative isolation and purification of anthocyanins from purple sweet potato by high-speed counter-current chromatography. J Sep Sci 2009, 32:2146-2151.
24. Ahmed M., Akter M.S., Eun J.B. Impact of alpha-amylase and maltodextrin on physicochemical, functional and antioxidant capacity of spray-dried purple sweet potato flour. J Sci Food Agric 2010, 90:494-502.
25. Choi J.H., Choi C.Y., Lee K.J., Hwang Y.P., Chung Y.C., Jeong H.G. Hepatoprotective effects of an anthocyanins fraction from purple-fleshed sweet potato against acetaminophen-induced liver damage in mice. J Med Food 2009, 12:320-326.
26. Choi J.H., Hwang Y.P., Choi C.Y., Chung Y.C., Jeong H.G. Anti-fibrotic effects of the anthocyanins isolated from the purple-fleshed sweet potato on hepatic fibrosis induced by dimethylnitrosamine administration in rats. Food Chem Toxicol 2010, 48:3137-3143.
27. Choi J.H., Hwang Y.P., Park B.H., Choi C.Y., Chung Y.C., Jeong H.G. Anthocyanins isolated from the purple-fleshed sweet potato attenuate the proliferation of hepatic stellate cells by blocking the PDGF receptor. Environ Toxicol Pharmacol 2011, 31:212-219.
28. Hwang Y.P., Choi J.H., Yun H.J., Han E.H., Kim H.G., Kim J.Y., et al. Anthocyanins from purple sweet potato attenuate dimethylnitrosamine-induced liver injury in rats by inducing Nrf2-mediated antioxidant enzymes and reducing COX-2 and iNOS expression. Food Chem Toxicol 2011, 49:93-99.
29. Lee L.S., Kim S.J., Rhim J.W. Analysis of anthocyanin pigments from purple-fleshed sweet potato (Jami). J Korean Soc Food Sci Nutr 2000, 29:555-560.
30. Tian Q., Konczak I., Schwartz S.J. Probing anthocyanins profiles in purple sweet potato cell line (Ipomoea batatas L. Cv. Ayamurasaki) by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry. J Agric Food Chem 2005, 53:6503-6509.
31. Lee L.S., Chang E.J., Rhim J.W., Ko B.S., Choi S.W. Isolation and identification of anthocyanins from purple sweet potatoes. J Food Sci Nutr 1997, 2:83-88.
32. Zang M., Zuccollo A., Hou X., Nagata D., Walsh K., Herscovitz H., et al. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J Biol Chem 2004, 279:47898-47905.
33. Lee K.J., Choi C.Y., Chung Y.C., Kim Y.S., Ryu S.Y., Roh S.H., et al. Protective effect of saponins derived from roots of Platycodon grandiflorum on tert-butyl hydroperoxide-induced oxidative hepatotoxicity. Toxicol Lett 2004, 147:271-282.
34. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
35. Lee Y.S., Kim W.S., Kim K.H., Yoon M.J., Cho H.J., Shen Y., et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006, 55:2256-2264.
36. Iglesias M.A., Ye J.M., Frangioudakis G., Saha A.K., Tomas E., Ruderman N.B., et al. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 2002, 51:2886-2894.
37. Hertog M.G., Hollman P.C., Katan M.B., Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 1993, 20:21-29.
38. de Pascual-Teresa S., Moreno D.A., Garćia-Viguera C. Flavanols and anthocyanins in cardiovascular health: a review of current evidence. Int J Mol Sci 2010, 11:1679-1703.
39. Mazza G. Scientific evidence in support of the health benefits of wine. Acta Hortic 2007, 754:577-585.
40. Meja-Meza E.I., Yanez J.A., Remsberg C.M., Takemoto J.K., Davies N.M., Rasco B., et al. Effect of dehydration on raspberries: polyphenol and anthocyanin retention, antioxidant capacity, and antiadipogenic activity. J Food Sci 2010, 75:H5-H12.
41. Pinent M., Bladëa M.C., Salvadöa M.J., Arola L., Ardëavol A. Metabolic fate of glucose on 3T3-L1 adipocytes treated with grape seed derived procyanidin extract (GSPE): comparison with the effects of insulin. J Agric Food Chem 2005, 53:5932-5935.
42. Jayaprakasam B., Vareed S.K., Olson L.K., Nair N.G. Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J Agric Food Chem 2005, 53:28-31.
43. Yuan H., Shyy J.Y., Martins-Green M. Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. J Hepatol 2009, 51:535-547.
44. Kim E.J., Jung S.N., Son K.H., Kim S.R., Ha T.Y., Park M.G., et al. Antidiabetes and antiobesity effect of cryptotanshinone via activation of AMP-activated protein kinase. Mol Pharmacol 2007, 72:62-72.
45. González-Périz A., Horrillo R., Ferré N., Gronert K., Dong B., Morán-Salvador E., et al. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 2009, 23:1946-1957.
46. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001, 108:1167-1174.
47. Schimmack G., Defronzo R.A., Musi N. AMP-activated protein kinase: role in metabolism and therapeutic implications. Diabetes Obes Metab 2006, 8:591-602.
48. Collins Q.F., Liu H.Y., Pi J., Liu Z., Quon M.J., Cao W. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase. J Biol Chem 2007, 282:30143-30149.
49. Hardie D.G. The AMP-activated protein kinase pathways new players upstream and downstream. J Cell Sci 2004, 117:5479-5487.
50. Kohjima M., Higuchi N., Kato M., Kotoh K., Yoshimoto T., Fujino T., et al. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med 2008, 21:507-511.
51. Park K.G., Min A.K., Koh E.H., Kim H.S., Kim M.O., Park H.S., et al. Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology 2008, 48:1477-1486.
52. Harada K., Kano M., Takayanagi T., Yamakawa O., Ishikawa F. Absorption of acylated anthocyanins in rats and humans after ingesting an extract of Ipomoea batatas purple sweet potato tuber. Biosci Biotechnol Biochem 2004, 68:1500-1507.
53. Oki T., Suda I., Terahara N., Sato M., Hatakeyama M. Determination of acylated anthocyanin in human urine after ingesting a purple-fleshed sweet potato beverage with various contents of anthocyanin by LC-ESI-MS/MS. Biosci Biotechnol Biochem 2006, 70:2540-2543.
54. Kano M., Takayanagi T., Harada K., Makino K., Ishikawa F. Antioxidative activity of anthocyanins from purple sweet potato, Ipomoea batatas cultivar ayamurasaki. Biosci Biotechnol Biochem 2005, 69:979-998.
55. Suda I., Oki T., Masuda M., Nishiba Y., Furuta S., Matsugano K., et al. Direct absorption of acylated anthocyanin in purple-fleshed sweet potato into rats. J Agric Food Chem 2002, 50:1672-1676.
56. Sanders M.J., Grondin P.O., Hegarty B.D., Snowden M.A., Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J 2007, 403:139-148.